Observations on the presentation, diagnosis, and treatment of interstitial cystitis in men

被引:40
作者
Forrest, JB
Vo, Q
机构
[1] Urol Specialists Oklahoma Inc, Tulsa, OK USA
[2] Univ Oklahoma, Hlth Sci Ctr, Tulsa, OK 74136 USA
关键词
D O I
10.1016/S0090-4295(01)01121-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This article presents and evaluates the symptoms, presentation, diagnosis, and treatment of men with interstitial cystitis (IC). A retrospective chart review and an interview of all men in our practice diagnosed with IC since 1990 was performed. The patients' presenting symptoms, physical findings, clinical evaluation, and responses to therapy were reviewed. A total of 52 men were identified during the study who met the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) criteria for diagnosis of IC. The most common referral diagnosis was prostatitis with the most common predominant symptoms being suprapubic pain with urinary frequency and dysuria. A significant number of male patients also developed sexual dysfunction. All patients met the NIDDK criteria for a diagnosis of IC, Multiple therapies were used for the treatment of these patients over the study period. Five patients were initially treated with dimethyl sulfoxide (DMSO) as a sole agent; however, all intravesically treated patients eventually failed this form of therapy. A total of 37 of 52 patients were treated with multidrug oral therapy. Findings showed that 80% of patients achieved > 75% improvement in their symptomology at 6 months of follow-up with a durable response at 1 year. IC in men is probably underdiagnosed and is most commonly misdiagnosed as prostatitis, The patient's presentation is analogous to that in the female population allowing for gender differences. The patients responded well to multidrug oral therapy. (C) 2001, Elsevier Science Inc.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 18 条
[1]   Bladder petechiae after cystoscopy and hydrodistension in men diagnosed with prostate pain [J].
Berger, RE ;
Miller, JE ;
Rothman, I ;
Krieger, JN ;
Muller, CH .
JOURNAL OF UROLOGY, 1998, 159 (01) :83-85
[2]   Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: An alternative explanation of its beneficial effect in interstitial cystitis [J].
Chiang, G ;
Patra, P ;
Letourneau, R ;
Jeudy, S ;
Boucher, W ;
Green, M ;
Sant, GR ;
Theoharides, TC .
JOURNAL OF UROLOGY, 2000, 164 (06) :2119-2125
[3]  
CRISTOL DS, 1944, JAMA-J AM MED ASSOC, V126, P824
[4]   SUMMARY OF THE NATIONAL-INSTITUTE-OF-ARTHRITIS-DIABETES-DIGESTIVE-AND-KIDNEY-DISEASESWORKSHOP ON INTERSTITIAL CYSTITIS, NATIONAL-INSTITUTES-OF-HEALTH, BETHESDA, MARYLAND, AUGUST 28-29, 1987 [J].
GILLENWATER, JY ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1988, 140 (01) :203-206
[5]   Analysis of long-term Elmiron therapy for interstitial cystitis [J].
Hanno, PM .
UROLOGY, 1997, 49 (5A) :93-99
[6]   The diagnosis of interstitial cystitis revisited: Lessons learned from the National Institutes of Health Interstitial Cystitis Database study [J].
Hanno, PM ;
Landis, JR ;
Matthews-Cook, Y ;
Kusek, J ;
Nyberg, L .
JOURNAL OF UROLOGY, 1999, 161 (02) :553-557
[7]  
HELD DJ, 1990, INTERSTITIAL CYSTITI, P29
[8]  
Held PJ, 1990, Interstitial Cystitis, P29, DOI 10.1007/978-1-4471-3293-6_4
[9]   PROSTATODYNIA AND INTERSTITIAL CYSTITIS - ONE AND THE SAME [J].
MILLER, JL ;
ROTHMAN, I ;
BAVENDAM, TG ;
BERGER, RE .
UROLOGY, 1995, 45 (04) :587-590
[10]  
*NIH, 1998, 1 NIH INT CHRON PROS